Beijing Bori-Sino Pharmaceutical Co., Ltd.
Stock Trading Abnormal Fluctuation Announcement
The Company and the entire Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
I. Specifics of Stock Trading Abnormal Fluctuations
The stock of Beijing Bori-Sino Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") experienced cumulative closing price increases exceeding 30% on August 6, 2026, August 7, 2026, and August 10, 2026, for three consecutive trading days. In accordance with the relevant regulations of the Shenzhen Stock Exchange, this constitutes a stock trading abnormal fluctuation.
II. Company's Attention and Verification of Relevant Matters
Regarding the Company's stock trading abnormal fluctuation, the Company's Board of Directors has verified the relevant issues with the controlling shareholder and the actual controller. The relevant situation is hereby described as follows:
-
The information previously disclosed by the Company does not require correction or supplementation.
-
The Company has not found any undisclosed material information in recent public media reports that may have had or has had a significant impact on the Company's stock trading price.
-
The Company's current operating conditions and internal and external operating environment have not undergone and are not expected to undergo any significant changes.